Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109
In the published publication [...]
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Biosensors |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6374/12/10/794 |
_version_ | 1797474853075288064 |
---|---|
author | Albert Yu Xiaoyong Dai Zixian Wang Huaqing Chen Bing Guo Laiqiang Huang |
author_facet | Albert Yu Xiaoyong Dai Zixian Wang Huaqing Chen Bing Guo Laiqiang Huang |
author_sort | Albert Yu |
collection | DOAJ |
description | In the published publication [...] |
first_indexed | 2024-03-09T20:35:57Z |
format | Article |
id | doaj.art-67de6d599295497b9e76bde3e583e9fa |
institution | Directory Open Access Journal |
issn | 2079-6374 |
language | English |
last_indexed | 2024-03-09T20:35:57Z |
publishDate | 2022-09-01 |
publisher | MDPI AG |
record_format | Article |
series | Biosensors |
spelling | doaj.art-67de6d599295497b9e76bde3e583e9fa2023-11-23T23:10:46ZengMDPI AGBiosensors2079-63742022-09-01121079410.3390/bios12100794Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109Albert Yu0Xiaoyong Dai1Zixian Wang2Huaqing Chen3Bing Guo4Laiqiang Huang5Precision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaPrecision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaPrecision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaPrecision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaSchool of Science and Shenzhen Key Laboratory of Flexible Printed Electronics Technology, Harbin Institute of Technology, Shenzhen 518055, ChinaPrecision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaIn the published publication [...]https://www.mdpi.com/2079-6374/12/10/794n/a |
spellingShingle | Albert Yu Xiaoyong Dai Zixian Wang Huaqing Chen Bing Guo Laiqiang Huang Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109 Biosensors n/a |
title | Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109 |
title_full | Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109 |
title_fullStr | Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109 |
title_full_unstemmed | Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109 |
title_short | Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109 |
title_sort | correction yu et al recent advances of mesoporous silica as a platform for cancer immunotherapy i biosensors i 2022 i 12 i 109 |
topic | n/a |
url | https://www.mdpi.com/2079-6374/12/10/794 |
work_keys_str_mv | AT albertyu correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109 AT xiaoyongdai correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109 AT zixianwang correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109 AT huaqingchen correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109 AT bingguo correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109 AT laiqianghuang correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109 |